| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1286-4579(02)01653-2 |
| P698 | PubMed publication ID | 12467767 |
| P2093 | author name string | Hugo R Rosen | |
| P2860 | cites work | The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation | Q77220720 |
| Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain | Q24529494 | ||
| Retransplantation for hepatitis C: implications of different policies | Q34085375 | ||
| Liver transplantation: current status and novel approaches to liver replacement | Q34141313 | ||
| Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin | Q34178224 | ||
| Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients | Q34415766 | ||
| Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease | Q40819259 | ||
| HCV-related fibrosis progression following liver transplantation: increase in recent years | Q41732518 | ||
| Hepatitis C infection in patients undergoing liver retransplantation | Q42689659 | ||
| Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions. | Q42980400 | ||
| Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. | Q42984860 | ||
| A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation | Q42987942 | ||
| Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation | Q42987960 | ||
| Predictors of patient and graft survival following liver transplantation for hepatitis C. | Q42989860 | ||
| Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts | Q42993989 | ||
| Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation | Q43000722 | ||
| Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers | Q43034244 | ||
| Long-term outcome of hepatitis C infection after liver transplantation | Q43046814 | ||
| A longitudinal analysis of hepatitis C virus replication following liver transplantation | Q43047520 | ||
| Quantitation of hepatitis C virus RNA in liver transplant recipients | Q43049255 | ||
| Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation | Q44654522 | ||
| Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation | Q45740469 | ||
| A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. | Q54125455 | ||
| OKT3 and hepatitis C: defining the risks | Q72989954 | ||
| Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial | Q74111659 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1253-1258 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Microbes and Infection | Q15760242 |
| P1476 | title | Hepatitis C in the liver transplant recipient: current understanding and treatment | |
| P478 | volume | 4 |
Search more.